CVRx preliminary Q1 revenue $12.3M (+15% YoY) but below expectations; cites seasonality, new rep ramp

CVRx, Inc.

2025-Q1 EPS reported -$0.53 revenue$12,348,000

Preliminary Q1 2025 revenue ~$12.3M, up 15% YoY from $10.8M.
U.S. revenue ~$11.2M; European revenue ~$1.1M.
Active U.S. implant centers 227 (up from 223 at year-end); sales territories reduced to 45.
Cash and equivalents $102.7M; issued 543,462 shares for $9.5M under ATM in Q1.
CEO noted revenue fell short due to new sales reps developing and Q1 seasonality; full results due May 8.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.